Right tools, Right application, Right answer Maria Zambon Public - - PowerPoint PPT Presentation

right tools right application
SMART_READER_LITE
LIVE PREVIEW

Right tools, Right application, Right answer Maria Zambon Public - - PowerPoint PPT Presentation

Right tools, Right application, Right answer Maria Zambon Public Health England 2 T ools for Assessment of Disease Burden Changes in Diagnostic tools & capability 4 5 The Decreasing Cost of Genotype Information Improving Information


slide-1
SLIDE 1

Right tools, Right application, Right answer

Maria Zambon Public Health England

slide-2
SLIDE 2

2

slide-3
SLIDE 3

T

  • ols for Assessment of Disease Burden
slide-4
SLIDE 4

Changes in Diagnostic tools & capability

4

slide-5
SLIDE 5

5 The Decreasing Cost of Genotype Information

slide-6
SLIDE 6

Improving Information for Interventions

slide-7
SLIDE 7

Introduction of New technologies Top of the pyramid Case studies

slide-8
SLIDE 8

Paediatric Fatal Cases 2003-2004

Winter 2003-2004 : emergence antigenic variant A/Fujian/411/2002-like viruses Poor vaccine match Unusual high number of influenza fatalities in children: 17 fatal Sept -Dec 2003 in the UK No pre-existing risk factors None vaccinated Bacterial coinfection only in 3/17 (18%) cases WGS of all fatal cases & matched controls ( 1:3)

Galiano et al. PLoS One, 2012 WHOLE-GENOME TREE

slide-9
SLIDE 9

Findings

  • Fatal Cases distributed along all genetic

lineages

  • Several additional changes in internal genes

& reassortment events noted

  • No genetic changes associated with fatal
  • utcome
  • Host-related susceptibility  naïve unvaccinated

children undergoing first influenza infection

slide-10
SLIDE 10

First wave Second wave Third wave

ILI index Fatal cases

Fatal cases , A(H1N1) pandemic 2009 viruses

WGS comparison of viruses isolated from fatal and ‘control’ mild cases from first, second and third wave of pandemics in the UK

No genetic differences between viruses from fatal and mild cases Third wave viruses: Several signature changes Ongoing adaptation to host? Enhanced fitness? New virulence factors?

slide-11
SLIDE 11

Key findings

  • WGS fatal vs. non-fatal ….no specific genetic

changes associated with a fatal outcome, (HA- D222G  not enough evidence)

  • Variation observed in replication kinetics

between viral strains in different waves

  • Variation observed within and between

waves Clinical outcome of infection determined by host-related factors….

slide-12
SLIDE 12

Influenza clinical and public health challenges

slide-13
SLIDE 13

European early warning based on convergence of technologies

15/16

slide-14
SLIDE 14

Overall activity Influenza A 2014/15 Developing the information

slide-15
SLIDE 15
slide-16
SLIDE 16
slide-17
SLIDE 17
slide-18
SLIDE 18
slide-19
SLIDE 19
slide-20
SLIDE 20

Influenza clinical and public health challenges

slide-21
SLIDE 21

Crowd sourcing ?

slide-22
SLIDE 22

Eurosurveillance Research Article

slide-23
SLIDE 23
slide-24
SLIDE 24

The Big Picture

  • Switching technologies, improve prediction, increase

information strain diversity. WGS/NGS…unbiased information

  • Technology is ahead of Knowledge (Virus & patient)
  • STRATIFIED MEDICINE…Consider the host…link to

clinical outcome

  • Population Susceptibility….better methods for prediction of susceptibility
  • Study of vaccine failures will help improve vaccine

design Automated analysis of known drug resistance mutations Pay attention to the sample. Rubbish in = rubbish out.

slide-25
SLIDE 25

Implications & Issues

Moving to an unbiased approach to analysis Data analysis is bottleneck : We have more data than we know what to do with Powerful epidemiological analysis: new insights and hypothesis generation Data storage and release issues

25 Clinical and public health challenges of influenza